|
WO2007046489A1
(ja)
|
2005-10-21 |
2007-04-26 |
Chugai Seiyaku Kabushiki Kaisha |
心疾患治療剤
|
|
CN101495146B
(zh)
|
2006-04-07 |
2012-10-17 |
国立大学法人大阪大学 |
肌肉再生促进剂
|
|
US8080248B2
(en)
|
2006-06-02 |
2011-12-20 |
Regeneron Pharmaceuticals, Inc. |
Method of treating rheumatoid arthritis with an IL-6R antibody
|
|
MY159787A
(en)
|
2006-06-02 |
2017-01-31 |
Regeneron Pharma |
High affinity antibodies to human il-6 receptor
|
|
JP2010500876A
(ja)
|
2006-08-18 |
2010-01-14 |
アブリンクス エン．ヴェー． |
Ｉｌ−６媒介性シグナル伝達に関連する疾患及び障害の治療のための、ｉｌ−６ｒに指向性を有するアミノ酸配列及びこれを含むポリペプチド
|
|
JP2010512734A
(ja)
*
|
2006-12-13 |
2010-04-30 |
アブリンクス エン．ヴェー． |
Ｉｌ−６／ｉｌ−６受容体複合体等受容体介在性シグナル伝達に関与する複合体に特異的なポリペプチド
|
|
US9512236B2
(en)
|
2006-12-19 |
2016-12-06 |
Ablynx N.V. |
Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
|
|
ES2564392T3
(es)
|
2007-01-23 |
2016-03-22 |
Shinshu University |
Inhibidores de IL-6 para el tratamiento de rechazo crónico
|
|
KR101573086B1
(ko)
|
2007-06-25 |
2015-11-30 |
에스바테크 - 어 노바티스 컴파니 엘엘씨 |
항체를 변형시키는 방법, 및 기능적 특성이 개선된 변형된 항체
|
|
WO2009010539A2
(en)
*
|
2007-07-19 |
2009-01-22 |
Ablynx. N.V. |
Receptor for interleukin-6 (il-6) from macaca fascicularis
|
|
WO2009095489A2
(en)
*
|
2008-02-01 |
2009-08-06 |
Ablynx N.V. |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
|
|
CN101965362A
(zh)
*
|
2008-03-05 |
2011-02-02 |
埃博灵克斯股份有限公司 |
新型抗原结合二聚体-复合物及其制备方法和应用
|
|
CN102089325A
(zh)
|
2008-04-17 |
2011-06-08 |
埃博灵克斯股份有限公司 |
能够结合血清白蛋白的肽，以及包含其的化合物、构建体和多肽
|
|
EP2285408B1
(en)
|
2008-06-05 |
2018-10-24 |
Ablynx N.V. |
Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
|
|
JP5544290B2
(ja)
|
2008-06-05 |
2014-07-09 |
独立行政法人国立がん研究センター |
神経浸潤抑制剤
|
|
US8444976B2
(en)
|
2008-07-02 |
2013-05-21 |
Argen-X B.V. |
Antigen binding polypeptides
|
|
US9034325B2
(en)
|
2008-07-22 |
2015-05-19 |
Ablynx N.V. |
Amino acid sequences directed against multitarget scavenger receptors and polypeptides
|
|
TWI440469B
(zh)
|
2008-09-26 |
2014-06-11 |
Chugai Pharmaceutical Co Ltd |
Improved antibody molecules
|
|
CA2740561C
(en)
|
2008-10-14 |
2021-01-19 |
National Research Council Of Canada |
Bsa-specific antibodies
|
|
CN102307902B
(zh)
*
|
2008-12-10 |
2016-02-24 |
埃博灵克斯股份有限公司 |
用于治疗与血管发生相关的疾病和病症的针对血管生成素/Tie系统的氨基酸序列和包括其的多肽
|
|
CN102257003B
(zh)
|
2008-12-19 |
2017-04-05 |
埃博灵克斯股份有限公司 |
用于产生针对细胞相关抗原如p2x7、cxcr7或cxcr4的免疫球蛋白的基因免疫
|
|
ES2701649T3
(es)
|
2009-01-14 |
2019-02-25 |
Ablynx Nv |
Administración pulmonar de dominios variables individuales de inmunoglobulina y constructos de los mismos
|
|
EP2391652A4
(en)
*
|
2009-01-29 |
2013-01-02 |
Abbott Lab |
IL-1 BINDING PROTEINS
|
|
US10005830B2
(en)
|
2009-03-05 |
2018-06-26 |
Ablynx N.V. |
Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
|
|
US9265834B2
(en)
|
2009-03-05 |
2016-02-23 |
Ablynx N.V. |
Stable formulations of polypeptides and uses thereof
|
|
RU2524152C2
(ru)
*
|
2009-03-19 |
2014-07-27 |
Чугаи Сейяку Кабусики Кайся |
Средство для лечения ревматоидного артрита
|
|
US10618964B2
(en)
|
2009-04-10 |
2020-04-14 |
Ablynx N.V. |
Nanobody against IL-6R
|
|
KR101470690B1
(ko)
*
|
2009-04-10 |
2014-12-10 |
아블린쓰 엔.브이. |
Ｉｌ－６ｒ에 대한 개선된 아미노산 서열 및 ｉｌ－６ｒ 관련 질환 및 질병의 치료를 위한 그를 포함하는 폴리펩티드
|
|
EP2982690B1
(en)
|
2009-04-30 |
2021-01-27 |
Ablynx N.V. |
Method for the production of domain antibodies
|
|
PT2438087T
(pt)
|
2009-06-05 |
2017-08-04 |
Ablynx Nv |
Construções de nanobody trivalentes de vírus sincicial respiratório humano (hrsv) para a prevenção e/ou tratamento de infeções do trato respiratório
|
|
DK2451839T3
(da)
|
2009-07-10 |
2020-07-13 |
Ablynx Nv |
Fremgangsmåde til produktion af variable domæner
|
|
US9884117B2
(en)
|
2009-09-03 |
2018-02-06 |
Ablynx N.V. |
Stable formulations of polypeptides and uses thereof
|
|
WO2011030107A1
(en)
|
2009-09-10 |
2011-03-17 |
Ucb Pharma S.A. |
Multivalent antibodies
|
|
US20110195494A1
(en)
|
2009-10-02 |
2011-08-11 |
Boehringer Ingelheim International Gmbh |
Dll4-binging molecules
|
|
US20110172398A1
(en)
|
2009-10-02 |
2011-07-14 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules for anti-angiogenesis therapy
|
|
EP2486056A1
(en)
|
2009-10-09 |
2012-08-15 |
Ablynx N.V. |
Immunoglobulin single variable domain directed against human cxcr4 and other cell associated proteins and methods to generate them
|
|
EP2507262A1
(en)
|
2009-11-30 |
2012-10-10 |
Ablynx N.V. |
Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
|
|
EP2506874A1
(en)
|
2009-12-01 |
2012-10-10 |
Ablynx N.V. |
Von willebrand factor specific binding agents and uses thereof
|
|
US8962807B2
(en)
|
2009-12-14 |
2015-02-24 |
Ablynx N.V. |
Single variable domain antibodies against OX40L, constructs and therapeutic use
|
|
WO2011083141A2
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Method for generation of immunoglobulin sequences by using lipoprotein particles
|
|
JO3417B1
(ar)
|
2010-01-08 |
2019-10-20 |
Regeneron Pharma |
الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
|
|
EP2531523A1
(en)
|
2010-02-05 |
2012-12-12 |
Ablynx N.V. |
Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same
|
|
US9120855B2
(en)
|
2010-02-10 |
2015-09-01 |
Novartis Ag |
Biologic compounds directed against death receptor 5
|
|
WO2011098518A2
(en)
|
2010-02-11 |
2011-08-18 |
Ablynx Nv |
Delivery of immunoglobulin variable domains and constructs thereof
|
|
PT2533761T
(pt)
|
2010-02-11 |
2019-06-17 |
Ablynx Nv |
Métodos e composições para a preparação de aerossóis
|
|
PE20130527A1
(es)
|
2010-03-03 |
2013-05-09 |
Boehringer Ingelheim Int |
Polipeptidos de union a a-beta biparatopicos
|
|
EP2552962B1
(en)
|
2010-03-26 |
2016-03-23 |
Ablynx N.V. |
Immunoglobulin single variable domains directed against cxcr7
|
|
WO2013174537A1
(en)
|
2012-05-24 |
2013-11-28 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
|
US9556273B2
(en)
|
2010-03-29 |
2017-01-31 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
|
US9101674B2
(en)
|
2010-03-29 |
2015-08-11 |
Vib Vzw |
Targeting and in vivo imaging of tumor-associated macrophages
|
|
SG185354A1
(en)
|
2010-05-20 |
2012-12-28 |
Ablynx Nv |
Biological materials related to her3
|
|
EP4115906A1
(en)
|
2010-05-28 |
2023-01-11 |
Chugai Seiyaku Kabushiki Kaisha |
Antitumor t cell response enhancer
|
|
CA2802775C
(en)
*
|
2010-06-17 |
2019-09-24 |
Vib Vzw |
Increased protein expression through increased membrane formation
|
|
WO2011161263A1
(en)
|
2010-06-25 |
2011-12-29 |
Ablynx Nv |
Pharmaceutical compositions for cutaneous administration
|
|
US20120225081A1
(en)
|
2010-09-03 |
2012-09-06 |
Boehringer Ingelheim International Gmbh |
Vegf-binding molecules
|
|
US11644471B2
(en)
|
2010-09-30 |
2023-05-09 |
Ablynx N.V. |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
|
|
WO2012042026A1
(en)
|
2010-09-30 |
2012-04-05 |
Ablynx Nv |
Biological materials related to c-met
|
|
EP3575321B1
(en)
|
2010-11-08 |
2023-07-26 |
Ablynx N.V. |
Cxcr2 binding polypeptides
|
|
JP6181040B2
(ja)
*
|
2011-03-28 |
2017-08-16 |
アブリンクス エン．ヴェー． |
二特異性抗ｃｘｃｒ７免疫グロブリン単一可変ドメイン
|
|
US20130078247A1
(en)
|
2011-04-01 |
2013-03-28 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules binding to dii4 and ang2
|
|
US9527925B2
(en)
|
2011-04-01 |
2016-12-27 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules binding to VEGF and ANG2
|
|
UA117218C2
(uk)
|
2011-05-05 |
2018-07-10 |
Мерк Патент Гмбх |
Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f
|
|
WO2012152823A1
(en)
|
2011-05-09 |
2012-11-15 |
Ablynx Nv |
Method for the production of immunoglobulin single variable domains
|
|
AU2012264809B2
(en)
|
2011-05-27 |
2017-05-04 |
Ablynx Nv |
Inhibition of bone resorption with RANKL binding peptides
|
|
EP4282882A3
(en)
|
2011-06-21 |
2024-03-06 |
Vib Vzw |
Binding domains directed against gpcr:g protein complexes and uses derived thereof
|
|
EP3020728A1
(en)
|
2011-06-23 |
2016-05-18 |
Ablynx N.V. |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobin single variable domains
|
|
JP2014525736A
(ja)
|
2011-06-23 |
2014-10-02 |
アブリンクス エン．ヴェー． |
ＩｇＥに対する免疫グロブリン単一可変ドメイン
|
|
SG194982A1
(en)
|
2011-06-23 |
2013-12-30 |
Ablynx Nv |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
|
|
CN106046168A
(zh)
|
2011-06-23 |
2016-10-26 |
埃博灵克斯股份有限公司 |
结合血清白蛋白的蛋白
|
|
EP4350345A3
(en)
|
2011-06-23 |
2024-07-24 |
Ablynx N.V. |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobin single variable domains
|
|
UA118833C2
(uk)
|
2011-08-17 |
2019-03-25 |
Ґлаксо Ґруп Лімітед |
Одиничний варіабельний домен імуноглобуліну, який зв'язується з tnfr1
|
|
WO2013041722A1
(en)
|
2011-09-23 |
2013-03-28 |
Ablynx Nv |
Prolonged inhibition of interleukin-6 mediated signaling
|
|
US9346884B2
(en)
|
2011-09-30 |
2016-05-24 |
Ablynx N.V. |
Biological materials related to c-Met
|
|
JP6219287B2
(ja)
|
2011-09-30 |
2017-10-25 |
アブリンクス エン．ヴェー． |
ｃ−Ｍｅｔに関連する生物学的物質
|
|
TWI589299B
(zh)
|
2011-10-11 |
2017-07-01 |
再生元醫藥公司 |
用於治療類風濕性關節炎之組成物及其使用方法
|
|
MX2014009129A
(es)
|
2012-01-26 |
2014-11-21 |
Amgen Inc |
Polipeptidos de factor 15 de diferenciacion de crecimiento (gdf-15).
|
|
PH12021553014A1
(en)
|
2012-02-27 |
2022-09-05 |
Ablynx Nv |
Cx3cr1-binding polypeptides
|
|
DK2831111T3
(en)
|
2012-03-30 |
2019-04-29 |
Boehringer Ingelheim Int |
Ang2-binding molecules
|
|
US9328174B2
(en)
|
2012-05-09 |
2016-05-03 |
Novartis Ag |
Chemokine receptor binding polypeptides
|
|
WO2014087010A1
(en)
|
2012-12-07 |
2014-06-12 |
Ablynx N.V. |
IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
|
|
CN105102478A
(zh)
|
2013-01-30 |
2015-11-25 |
弗拉芒区生物技术研究所 |
用于筛选和药物发现目的的新型嵌合多肽
|
|
PT2953973T
(pt)
|
2013-02-05 |
2019-10-25 |
Univ Brussel Vrije |
Agentes de ligação do receptor muscarínico de acetilololina e usos
|
|
WO2014140376A1
(en)
|
2013-03-15 |
2014-09-18 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for use in cardiovascular diseases
|
|
US10782290B2
(en)
|
2013-06-11 |
2020-09-22 |
National Center Of Neurology And Psychiatry |
Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy
|
|
LT3027642T
(lt)
*
|
2013-07-31 |
2020-10-12 |
Amgen Inc. |
Augimo ir diferenciacijos faktoriaus 15(gdf-15) konstruktai
|
|
EP3447068A1
(en)
|
2013-11-04 |
2019-02-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Synthetic single domain antibody
|
|
EP2873680A1
(en)
*
|
2013-11-13 |
2015-05-20 |
F.Hoffmann-La Roche Ag |
Oligopeptide and methods for producing conjugates thereof
|
|
US9017678B1
(en)
|
2014-07-15 |
2015-04-28 |
Kymab Limited |
Method of treating rheumatoid arthritis using antibody to IL6R
|
|
US20160326220A1
(en)
|
2013-12-24 |
2016-11-10 |
Vib Vzw |
Secretion and functional display of chimeric polypeptides
|
|
CA2936728C
(en)
|
2014-01-30 |
2023-06-20 |
Vib Vzw |
Opioid receptor binding agents and uses thereof
|
|
EP3143403B1
(en)
|
2014-05-16 |
2021-10-27 |
Ablynx N.V. |
Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies
|
|
IL318433A
(en)
|
2014-05-16 |
2025-03-01 |
Ablynx Nv |
Improved immunoglobulin variable complexes
|
|
RS63085B1
(sr)
|
2014-05-16 |
2022-04-29 |
Ablynx Nv |
Varijabilni domeni imunoglobulina
|
|
NL2013007B1
(en)
|
2014-06-16 |
2016-07-05 |
Ablynx Nv |
Methods of treating TTP with immunoglobulin single variable domains and uses thereof.
|
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
|
CA2955554C
(en)
|
2014-07-22 |
2022-07-05 |
Vib Vzw |
Methods to select for agents that stabilize protein complexes
|
|
PL3204018T3
(pl)
|
2014-10-07 |
2022-01-03 |
Immunomedics, Inc. |
Neoadiuwantowe zastosowanie koniugatów przeciwciało-lek
|
|
AU2015334984A1
(en)
|
2014-10-21 |
2017-04-13 |
Ablynx Nv |
Treatment of IL-6R related diseases
|
|
EP3233910B1
(en)
|
2014-12-19 |
2019-12-11 |
Ablynx N.V. |
Cysteine linked nanobody dimers
|
|
KR101892883B1
(ko)
|
2015-02-27 |
2018-10-05 |
추가이 세이야쿠 가부시키가이샤 |
Il-6 관련 질환 치료용 조성물
|
|
US11306139B2
(en)
*
|
2015-03-20 |
2022-04-19 |
Ablynx N.V. |
Glycosylated immunoglobulin single variable domains
|
|
WO2016156468A1
(en)
|
2015-03-31 |
2016-10-06 |
Vhsquared Limited |
Polypeptides
|
|
CN107427577A
(zh)
|
2015-03-31 |
2017-12-01 |
韦斯夸尔德有限公司 |
具有蛋白酶可切割接头的肽构建体
|
|
US10273305B2
(en)
|
2015-04-02 |
2019-04-30 |
Ablynx N.V. |
Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
|
|
CA2981543A1
(en)
|
2015-04-22 |
2016-10-27 |
Immunomedics, Inc. |
Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells
|
|
ES2984656T3
(es)
|
2015-05-13 |
2024-10-30 |
Ablynx Nv |
Polipéptidos que reclutan linfocitos T en función de la reactividad a CD3
|
|
ES2754427T3
(es)
|
2015-05-13 |
2020-04-17 |
Ablynx Nv |
Polipéptidos de reclutamiento de células T basados en la reactividad de TCR alfa/beta
|
|
PL3299810T3
(pl)
|
2015-05-19 |
2021-12-13 |
National Center Of Neurology And Psychiatry |
Sposób określania zastosowania nowej terapii u pacjentów ze stwardnieniem rozsianym (sm)
|
|
SG10202002131PA
(en)
|
2015-05-21 |
2020-05-28 |
Harpoon Therapeutics Inc |
Trispecific binding proteins and methods of use
|
|
EP3316885B1
(en)
|
2015-07-01 |
2021-06-23 |
Immunomedics, Inc. |
Antibody-sn-38 immunoconjugates with a cl2a linker
|
|
NO2768984T3
(cg-RX-API-DMAC7.html)
|
2015-11-12 |
2018-06-09 |
|
|
|
PL3374392T3
(pl)
|
2015-11-13 |
2022-03-28 |
Ablynx Nv |
Ulepszone domeny zmienne immunoglobuliny wiążące albuminę surowicy
|
|
GEP20207174B
(en)
|
2015-11-18 |
2020-11-10 |
Merck Sharp & Dohme |
Ctla4 binders
|
|
WO2017087587A1
(en)
|
2015-11-18 |
2017-05-26 |
Merck Sharp & Dohme Corp. |
PD1/CTLA4 Binders
|
|
US11332519B2
(en)
|
2015-11-18 |
2022-05-17 |
Ablynx N.V. |
Serum albumin binders
|
|
SG10201911035QA
(en)
|
2015-11-18 |
2020-01-30 |
Merck Sharp & Dohme |
Pd1 and/or lag3 binders
|
|
SG11201803976VA
(en)
|
2015-11-27 |
2018-06-28 |
Ablynx Nv |
Polypeptides inhibiting cd40l
|
|
CN108289943B
(zh)
|
2015-12-04 |
2023-06-20 |
勃林格殷格翰国际有限公司 |
在肿瘤细胞中拮抗wnt信号传递的双互补位多肽
|
|
WO2017125578A1
(en)
|
2016-01-21 |
2017-07-27 |
Vhsquared Limited |
Polypeptides
|
|
US11186641B2
(en)
|
2016-03-17 |
2021-11-30 |
Oslo Universitetssykehus Hf |
Fusion proteins targeting tumour associated macrophages for treating cancer
|
|
JP2019523213A
(ja)
|
2016-05-02 |
2019-08-22 |
アブリンクス エン．ヴェー． |
Ｒｓｖ感染の処置
|
|
RS67145B1
(sr)
|
2016-05-20 |
2025-09-30 |
Harpoon Therapeutics Inc |
Proteini sa jednolančanim varijabilnim fragmentom koji vezuju cd3
|
|
CN109641047A
(zh)
|
2016-05-20 |
2019-04-16 |
哈普恩治疗公司 |
单结构域血清白蛋白结合蛋白质
|
|
US11623958B2
(en)
|
2016-05-20 |
2023-04-11 |
Harpoon Therapeutics, Inc. |
Single chain variable fragment CD3 binding proteins
|
|
EP3471761A2
(en)
|
2016-06-21 |
2019-04-24 |
University Of Oslo |
Hla binding vaccine moieties and uses thereof
|
|
JP7150618B2
(ja)
|
2016-06-23 |
2022-10-11 |
アブリンクス エン．ヴェー． |
免疫グロブリン単一可変ドメインについての改善された薬物動態アッセイ
|
|
WO2018007442A1
(en)
|
2016-07-06 |
2018-01-11 |
Ablynx N.V. |
Treatment of il-6r related diseases
|
|
WO2018029182A1
(en)
|
2016-08-08 |
2018-02-15 |
Ablynx N.V. |
Il-6r single variable domain antibodies for treatment of il-6r related diseases
|
|
EP3512880A1
(en)
|
2016-09-15 |
2019-07-24 |
Ablynx NV |
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
|
|
ES3033182T3
(en)
|
2016-09-20 |
2025-07-31 |
Dana Farber Cancer Inst Inc |
Compositions and methods for identification, assessment, prevention, and treatment of aml using usp10 biomarkers and modulators
|
|
WO2018060453A1
(en)
|
2016-09-30 |
2018-04-05 |
Vhsquared Limited |
Compositions
|
|
IL266506B2
(en)
|
2016-11-16 |
2025-05-01 |
Ablynx Nv |
T cell recruiting polypeptides capable of binding cd123 and tcr alpha/beta
|
|
KR20210087108A
(ko)
|
2016-11-23 |
2021-07-09 |
하푼 테라퓨틱스, 인크. |
전립선 특이 막 항원 결합 단백질
|
|
EP3544629A4
(en)
|
2016-11-23 |
2020-06-17 |
Harpoon Therapeutics, Inc. |
PSMA TO BE TRISPECIFIC PROTEINS AND METHOD FOR USE THEREOF
|
|
MX2019005947A
(es)
|
2016-11-28 |
2019-08-26 |
Chugai Pharmaceutical Co Ltd |
Molecula de union a ligando que tiene actividad de union a ligando ajustable.
|
|
WO2018099968A1
(en)
|
2016-11-29 |
2018-06-07 |
Ablynx N.V. |
Treatment of infection by respiratory syncytial virus (rsv)
|
|
WO2018104444A1
(en)
|
2016-12-07 |
2018-06-14 |
Ablynx Nv |
Improved serum albumin binding immunoglobulin single variable domains
|
|
WO2018111099A1
(en)
|
2016-12-12 |
2018-06-21 |
Stichting Vumc |
Biomarkers and treatments for cerebral amyloid angiopathy (caa)
|
|
WO2018134234A1
(en)
|
2017-01-17 |
2018-07-26 |
Ablynx Nv |
Improved serum albumin binders
|
|
DK3571225T3
(da)
|
2017-01-17 |
2024-11-04 |
Ablynx Nv |
Forbedrede serumalbuminbindere
|
|
WO2018160754A2
(en)
|
2017-02-28 |
2018-09-07 |
Harpoon Therapeutics, Inc. |
Inducible monovalent antigen binding protein
|
|
EP3589725A1
(en)
|
2017-02-28 |
2020-01-08 |
Vib Vzw |
Means and methods for oral protein delivery
|
|
WO2018178307A1
(en)
|
2017-03-31 |
2018-10-04 |
Ablynx N.V. |
Improved immunogenicity assays
|
|
WO2018203545A1
(ja)
|
2017-05-02 |
2018-11-08 |
国立研究開発法人国立精神・神経医療研究センター |
Ｉｌ－６及び好中球の関連する疾患の治療効果の予測及び判定方法
|
|
CA3062238A1
(en)
|
2017-05-11 |
2018-11-15 |
Vib Vzw |
Glycosylation of variable immunoglobulin domains
|
|
CN121159691A
(zh)
|
2017-05-12 |
2025-12-19 |
哈普恩治疗公司 |
间皮素结合蛋白质
|
|
CN110913908B
(zh)
|
2017-05-12 |
2022-05-27 |
哈普恩治疗公司 |
靶向msln的三特异性蛋白质及使用方法
|
|
ES2979194T3
(es)
|
2017-05-31 |
2024-09-24 |
Boehringer Ingelheim Int |
Polipéptidos que antagonizan la señalización WNT en células tumorales
|
|
US11603401B2
(en)
|
2017-06-02 |
2023-03-14 |
Ablynx N.V. |
Aggrecan binding immunoglobulins
|
|
US11813307B2
(en)
|
2017-06-02 |
2023-11-14 |
Merck Patent Gmbh |
Polypeptides binding ADAMTS5, MMP13 and aggrecan
|
|
BR112019025097A2
(pt)
|
2017-06-02 |
2020-07-28 |
Merck Patent Gmbh |
imunoglobulinas de ligação a mmp13
|
|
US11261260B2
(en)
|
2017-06-02 |
2022-03-01 |
Merck Patent Gmbh |
ADAMTS binding immunoglobulins
|
|
US11820822B2
(en)
|
2017-06-06 |
2023-11-21 |
Dana-Farber Cancer Institute, Inc. |
Methods for sensitizing cancer cells to T cell-mediated killing by modulating molecular pathways
|
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
|
WO2019016237A1
(en)
|
2017-07-19 |
2019-01-24 |
Vib Vzw |
AGENTS FOR CONNECTING TO SERUM ALBUMIN
|
|
EP3683234A1
(en)
|
2017-09-13 |
2020-07-22 |
Jiangsu Hengrui Medicine Co., Ltd. |
Il-6r antibody and antigen binding fragment thereof and medical use
|
|
CN107492601A
(zh)
*
|
2017-09-30 |
2017-12-19 |
京东方科技集团股份有限公司 |
一种显示器件及其封装方法、显示装置
|
|
EA202090817A1
(ru)
|
2017-10-13 |
2020-09-08 |
Харпун Терапьютикс, Инк. |
Триспецифические белки и способы их применения
|
|
IL315737A
(en)
|
2017-10-13 |
2024-11-01 |
Harpoon Therapeutics Inc |
B-cell maturation antigen-binding proteins
|
|
EP3698808B1
(en)
|
2017-10-20 |
2025-01-01 |
Hyogo College Of Medicine |
Anti-il-6 receptor antibody-containing medicinal composition for preventing post-surgical adhesion
|
|
EP3704160B1
(en)
|
2017-10-31 |
2025-08-20 |
Vib Vzw |
Novel antigen-binding chimeric proteins and methods and uses thereof
|
|
ES3050257T3
(en)
|
2017-11-15 |
2025-12-19 |
Novo Nordisk As |
Factor x binders enhancing fx activation
|
|
KR20250134208A
(ko)
|
2017-11-28 |
2025-09-09 |
추가이 세이야쿠 가부시키가이샤 |
항원 결합 도메인 및 운반 부분을 포함하는 폴리펩티드
|
|
KR20200089312A
(ko)
|
2017-11-28 |
2020-07-24 |
추가이 세이야쿠 가부시키가이샤 |
리간드 결합 활성을 조정 가능한 리간드 결합 분자
|
|
WO2019147831A1
(en)
|
2018-01-26 |
2019-08-01 |
Regeneron Pharmaceuticals, Inc. |
Anti-tmprss2 antibodies and antigen-binding fragments
|
|
CN111670202A
(zh)
|
2018-02-06 |
2020-09-15 |
埃博灵克斯股份有限公司 |
以免疫球蛋白单可变结构域治疗ttp初次发作的方法
|
|
WO2019155041A1
(en)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
|
|
US20200392512A1
(en)
|
2018-02-26 |
2020-12-17 |
Ablynx N.V. |
Nucleotide sequences encoding peptide linkers
|
|
WO2019168897A2
(en)
|
2018-02-28 |
2019-09-06 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating cancer using combinations of anti-btnl2 and immune checkpoint blockade agents
|
|
EP3758742A1
(en)
|
2018-03-01 |
2021-01-06 |
Vrije Universiteit Brussel |
Human pd-l1-binding immunoglobulins
|
|
BR112020020823A2
(pt)
|
2018-04-09 |
2021-01-19 |
Amgen Inc. |
Proteínas de fusão do fator de diferenciação do crescimento 15
|
|
SG11202011330PA
(en)
|
2018-05-14 |
2020-12-30 |
Harpoon Therapeutics Inc |
Binding moiety for conditional activation of immunoglobulin molecules
|
|
WO2020061482A1
(en)
|
2018-09-21 |
2020-03-26 |
Harpoon Therapeutics, Inc. |
Egfr binding proteins and methods of use
|
|
AU2019346466A1
(en)
|
2018-09-25 |
2021-05-20 |
Harpoon Therapeutics, Inc. |
DLL3 binding proteins and methods of use
|
|
EP3636657A1
(en)
|
2018-10-08 |
2020-04-15 |
Ablynx N.V. |
Chromatography-free antibody purification method
|
|
KR20210122810A
(ko)
|
2019-01-31 |
2021-10-12 |
사노피 바이오테크놀로지 |
청소년 특발성 관절염을 치료하기 위한 항 il-6 수용체 항체
|
|
ES2984072T3
(es)
|
2019-03-08 |
2024-10-28 |
Linxis B V |
Moléculas de unión internalizantes que actúan sobre receptores implicados en la proliferación celular o en ladiferenciación celular
|
|
EP3959240A1
(en)
|
2019-04-24 |
2022-03-02 |
Sanofi Biotechnology |
Methods of diagnosis and treatment of rheumatoid arthritis
|
|
CN119569849A
(zh)
|
2019-04-29 |
2025-03-07 |
康福治疗有限公司 |
用于跨膜蛋白尤其是gpcr的筛选方法和测定
|
|
EP3962599A1
(en)
|
2019-04-30 |
2022-03-09 |
Vib Vzw |
Cystic fibrosis transmembrane conductance regulator stabilizing agents
|
|
US20220289854A1
(en)
|
2019-04-30 |
2022-09-15 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating cancer using combinations of anti-cx3cr1 and immune checkpoint blockade agents
|
|
WO2020239934A1
(en)
|
2019-05-28 |
2020-12-03 |
Vib Vzw |
Cd8+ t-cells lacking plexins and their application in cancer treatment
|
|
WO2020239945A1
(en)
|
2019-05-28 |
2020-12-03 |
Vib Vzw |
Cancer treatment by targeting plexins in the immune compartment
|
|
AU2020288561A1
(en)
|
2019-06-04 |
2021-12-23 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for treating pain in subjects with rheumatoid arthritis
|
|
US12247079B2
(en)
|
2019-06-21 |
2025-03-11 |
Sorriso Pharmaceuticals, Inc. |
Polynucleotides encoding, and method of making, a polypeptide comprising a VHH which binds interleukin-receptor (IL-7R)
|
|
AU2020296979A1
(en)
|
2019-06-21 |
2022-02-24 |
Sorriso Pharmaceuticals, Inc. |
Polypeptides
|
|
WO2021053199A1
(en)
|
2019-09-20 |
2021-03-25 |
Invectys |
Single-domain antibodies directed against lilrb2
|
|
WO2021074695A1
(en)
|
2019-10-16 |
2021-04-22 |
Avacta Life Sciences Limited |
PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES.
|
|
WO2021078786A1
(en)
|
2019-10-21 |
2021-04-29 |
Vib Vzw |
Nanodisc-specific antigen-binding chimeric proteins
|
|
MX2022005678A
(es)
|
2019-11-11 |
2022-10-18 |
Ibi Ag Innovative Bio Insecticides Ltd |
Nanocuerpos para el control de insectos y usos de los mismos.
|
|
WO2021105438A1
(en)
|
2019-11-27 |
2021-06-03 |
Vib Vzw |
Positive allosteric modulators of the calcium-sensing receptor
|
|
WO2021113736A1
(en)
|
2019-12-05 |
2021-06-10 |
Massachusetts Institute Of Technology |
Single-domain antibody to chloramphenicol
|
|
PH12022551214A1
(en)
|
2019-12-06 |
2023-10-09 |
Ablynx Nv |
Polypeptides comprising immunoglobulin single variable domains targeting tnf# and il-23
|
|
WO2021110817A1
(en)
|
2019-12-06 |
2021-06-10 |
Ablynx Nv |
Polypeptides comprising immunoglobulin single variable domains targeting tnfa and ox40l
|
|
WO2021116182A1
(en)
|
2019-12-09 |
2021-06-17 |
Ablynx Nv |
Polypeptides comprising immunoglobulin single variable domains targeting il-13 and tslp
|
|
GB201918279D0
(en)
|
2019-12-12 |
2020-01-29 |
Vib Vzw |
Glycosylated single chain immunoglobulin domains
|
|
CA3165429A1
(en)
|
2019-12-20 |
2021-06-24 |
Vib Vzw |
Nanobody exchange chromatography
|
|
WO2021140205A1
(en)
|
2020-01-10 |
2021-07-15 |
Confo Therapeutics N.V. |
Methods for generating antibodies and antibody fragments and libraries comprising same
|
|
US20230075965A1
(en)
|
2020-01-24 |
2023-03-09 |
Constantine S. Mitsiades |
Uses of biomarkers for improving immunotherapy
|
|
WO2021156490A2
(en)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Corona virus binders
|
|
AU2021219671A1
(en)
|
2020-02-10 |
2022-07-14 |
Regeneron Pharmaceuticals, Inc. |
Anti-Tmprss2 Antibodies and Antigen-Binding Fragments
|
|
CA3170833A1
(en)
|
2020-02-21 |
2021-08-26 |
Harpoon Therapeutics, Inc. |
Flt3 binding proteins and methods of use
|
|
WO2021170540A1
(en)
|
2020-02-25 |
2021-09-02 |
Vib Vzw |
Leucine-rich repeat kinase 2 allosteric modulators
|
|
MX2022012278A
(es)
|
2020-03-30 |
2022-10-27 |
Ablynx Nv |
Metodo para la produccion y purificacion de dominios variables unicos de inmunoglobulina multivalentes.
|
|
CR20220552A
(es)
|
2020-04-02 |
2023-01-17 |
Regeneron Pharma |
Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno
|
|
WO2021213435A1
(zh)
|
2020-04-22 |
2021-10-28 |
迈威(上海)生物科技股份有限公司 |
一种靶向人程序性死亡配体1(pd-l1)的单可变域抗体及其衍生物
|
|
KR20230009502A
(ko)
*
|
2020-05-18 |
2023-01-17 |
바이오션, 인코포레이티드 |
Il6r에 결합하는 항체 및 이의 용도
|
|
IL298194A
(en)
|
2020-05-26 |
2023-01-01 |
Regeneron Pharma |
Antibodies against sars-cov2-spike glycoprotein and antigen-binding fragments
|
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
|
WO2022003156A1
(en)
|
2020-07-02 |
2022-01-06 |
Oncurious Nv |
Ccr8 non-blocking binders
|
|
EP4214235A1
(en)
|
2020-09-16 |
2023-07-26 |
LinXis B.V. |
Internalizing binding molecules
|
|
WO2022063947A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Combination of p2y6 inhibitors and immune checkpoint inhibitors
|
|
WO2022063957A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Biomarker for anti-tumor therapy
|
|
MX2023003522A
(es)
|
2020-09-25 |
2023-04-19 |
Ablynx Nv |
Polipeptidos que comprenden dominios variables unicos de inmunoglobulina que se dirigen a il-13 y ox40l.
|
|
JP2023548046A
(ja)
|
2020-10-23 |
2023-11-15 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
抗ｃ５抗体を使用する、補体障害を有する患者の処置方法
|
|
WO2022117569A1
(en)
|
2020-12-02 |
2022-06-09 |
Oncurious Nv |
A ccr8 antagonist antibody in combination with a lymphotoxin beta receptor agonist antibody in therapy against cancer
|
|
US20240018248A1
(en)
|
2020-12-02 |
2024-01-18 |
Vib Vzw |
An ltbr agonist in combination therapy against cancer
|
|
PH12023500013A1
(en)
|
2020-12-04 |
2024-03-11 |
Tidal Therapeutics Inc |
Ionizable cationic lipids and lipi nanoparticles, and methods of synthesis and use thereof
|
|
US11946055B2
(en)
*
|
2020-12-10 |
2024-04-02 |
The Regents Of The University Of California |
Protein engineering via error-prone orthogonal replication and yeast surface display
|
|
WO2022129572A1
(en)
|
2020-12-18 |
2022-06-23 |
Ablynx Nv |
Polypeptides comprising immunoglobulin single variable domains targeting il-6 and tnf-alpha
|
|
KR20230123495A
(ko)
|
2020-12-18 |
2023-08-23 |
아블린쓰 엔.브이. |
글리피칸-3 및 t세포 수용체를 표적으로 하는 면역글로불린단일 가변 도메인을 포함하는 폴리펩티드
|
|
AU2021402090A1
(en)
|
2020-12-18 |
2023-08-03 |
Ablynx Nv |
T cell recruiting polypeptides based on tcr alpha/beta reactivity
|
|
GB202020502D0
(en)
|
2020-12-23 |
2021-02-03 |
Vib Vzw |
Antibody composistion for treatment of corona virus infection
|
|
WO2022136647A1
(en)
|
2020-12-24 |
2022-06-30 |
Oncurious Nv |
Human ccr8 binders
|
|
EP4267621A1
(en)
|
2020-12-24 |
2023-11-01 |
Vib Vzw |
Murine cross-reactive human ccr8 binders
|
|
WO2022136649A1
(en)
|
2020-12-24 |
2022-06-30 |
Oncurious Nv |
Non-blocking human ccr8 binders
|
|
WO2022159793A2
(en)
|
2021-01-25 |
2022-07-28 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for identifying neuroendocrine prostate cancer
|
|
CN117794566A
(zh)
|
2021-02-05 |
2024-03-29 |
Vib研究所 |
沙贝病毒结合剂
|
|
IL304929A
(en)
|
2021-02-05 |
2023-10-01 |
Vib Vzw [Be/Be |
Sarbecovirus binders
|
|
JP2024508692A
(ja)
|
2021-02-11 |
2024-02-28 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
Ｓｔｉｎｇアゴニストを使用してがんを治療する方法
|
|
CN117241804A
(zh)
|
2021-02-17 |
2023-12-15 |
非营利性组织佛兰芒综合大学生物技术研究所 |
在癌症治疗中slc4a4的抑制
|
|
EP4294834A2
(en)
|
2021-02-19 |
2023-12-27 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Single domain antibodies that neutralize sars-cov-2
|
|
IL305318A
(en)
|
2021-02-19 |
2023-10-01 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders
|
|
AU2022229805A1
(en)
|
2021-03-02 |
2023-09-21 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating red blood cell disorders
|
|
WO2022187626A1
(en)
|
2021-03-05 |
2022-09-09 |
Regeneron Pharmaceuticals, Inc. |
Anti-sars-cov-2-variant-spike glycoprotein antibodies and antigen-binding fragments
|
|
EP4319800A1
(en)
|
2021-04-07 |
2024-02-14 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for the treatment of cancer
|
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
|
US20240280561A1
(en)
|
2021-06-08 |
2024-08-22 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating and/or identifying an agent for treating intestinal cancers
|
|
WO2022268993A1
(en)
|
2021-06-23 |
2022-12-29 |
Vib Vzw |
Means and methods for selection of specific binders
|
|
KR20240046322A9
(ko)
|
2021-07-14 |
2025-10-01 |
리제너론 파아마슈티컬스, 인크. |
항-sars-cov-2-스파이크 당단백질 항체 및 항원-결합 단편
|
|
JP2024530455A
(ja)
|
2021-07-30 |
2024-08-21 |
ブイアイビー ブイゼットダブリュ |
標的化タンパク質の分解のためのカチオン非依存性マンノース６リン酸受容体結合体
|
|
EP4413038A1
(en)
|
2021-10-07 |
2024-08-14 |
Avacta Life Sciences Limited |
Pd-l1 binding affimers
|
|
WO2023057946A1
(en)
|
2021-10-07 |
2023-04-13 |
Avacta Life Sciences Limited |
Serum half-life extended pd-l1 binding polypeptides
|
|
CN114085287B
(zh)
*
|
2021-11-12 |
2022-10-25 |
中国农业科学院北京畜牧兽医研究所 |
犬细小病毒纳米抗体cpv-vhh-f5及其应用
|
|
WO2023091704A1
(en)
|
2021-11-18 |
2023-05-25 |
Circularis Biotechnologies, Inc. |
Compositions and methods for production of circular nucleic acid molecules
|
|
CN118302818A
(zh)
|
2021-11-22 |
2024-07-05 |
阿布林克斯有限公司 |
获得目标多价免疫球蛋白单可变结构域的序列信息
|
|
US20250381241A1
(en)
|
2021-11-29 |
2025-12-18 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions to modulate riok2
|
|
WO2023111266A1
(en)
|
2021-12-17 |
2023-06-22 |
Ablynx Nv |
POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TCRαβ, CD33 AND CD123
|
|
CA3248241A1
(en)
|
2022-01-12 |
2023-07-20 |
Vib Vzw |
HUMAN NTCP BINDERS FOR THERAPEUTIC USE AND TARGETED LIVER ADMINISTRATION
|
|
EP4476250A1
(en)
|
2022-02-07 |
2024-12-18 |
Vib Vzw |
Engineered stabilizing aglycosylated fc-regions
|
|
WO2023153876A1
(ko)
|
2022-02-10 |
2023-08-17 |
주식회사 아피셀테라퓨틱스 |
Cd40l에 특이적으로 결합하는 스테핀 a 단백질 변이체 및 이의 용도
|
|
WO2023155902A1
(en)
|
2022-02-18 |
2023-08-24 |
Chongqing Mingdao Haoyue Biotechnology Co., Ltd. |
Intranasal formulations and anti-sars-cov-2-spike protein antibodies
|
|
US20250235534A1
(en)
|
2022-04-13 |
2025-07-24 |
Vib Vzw |
An LTBR Agonist In Combination Therapy Against Cancer
|
|
WO2023215498A2
(en)
*
|
2022-05-05 |
2023-11-09 |
Modernatx, Inc. |
Compositions and methods for cd28 antagonism
|
|
WO2023218243A1
(en)
|
2022-05-12 |
2023-11-16 |
Avacta Life Sciences Limited |
Lag-3/pd-l1 binding fusion proteins
|
|
AU2023273998A1
(en)
|
2022-05-18 |
2024-11-14 |
Exevir Bio Bv |
Sarbecovirus spike s2 subunit binders
|
|
US20240002331A1
(en)
|
2022-06-08 |
2024-01-04 |
Tidal Therapeutics, Inc. |
Ionizable cationic lipids and lipid nanoparticles, and methods of synthesis and use thereof
|
|
IL317588A
(en)
|
2022-06-14 |
2025-02-01 |
Ablynx Nv |
Single immunoglobulin variable sites targeting the T cell receptor
|
|
US20250304677A1
(en)
|
2022-07-04 |
2025-10-02 |
Vib Vzw |
Blood-Cerebrospinal Fluid Barrier Crossing Antibodies
|
|
CA3262048A1
(en)
|
2022-07-18 |
2024-01-25 |
Sanofi |
Cx3cr1-binding compounds, methods and uses thereof
|
|
KR20250042176A
(ko)
|
2022-07-27 |
2025-03-26 |
아블린쓰 |
신생아 fc 수용체의 특정 에피토프에 결합하는 폴리펩타이드
|
|
CN116162160B
(zh)
*
|
2022-08-05 |
2025-07-29 |
南京融捷康生物科技有限公司 |
一种抗il-6的单域抗体及其用途
|
|
AU2023330110A1
(en)
|
2022-08-22 |
2025-03-06 |
Abdera Therapeutics Inc. |
Dll3 binding molecules and uses thereof
|
|
EP4594348A1
(en)
|
2022-09-27 |
2025-08-06 |
Vib Vzw |
Antivirals against human parainfluenza virus
|
|
TW202430561A
(zh)
|
2022-09-30 |
2024-08-01 |
法商賽諾菲公司 |
抗cd28抗體
|
|
EP4605077A1
(en)
|
2022-10-18 |
2025-08-27 |
Confo Therapeutics N.V. |
Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders
|
|
EP4608859A1
(en)
|
2022-10-25 |
2025-09-03 |
Ablynx N.V. |
Glycoengineered fc variant polypeptides with enhanced effector function
|
|
JP2025538184A
(ja)
|
2022-11-09 |
2025-11-26 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
先天性の抗腫瘍免疫を誘発する免疫刺激要因としてのトール様受容体７アゴニスト
|
|
US12195546B2
(en)
|
2022-12-19 |
2025-01-14 |
Sanofi |
CD28/OX40 bispecific antibodies
|
|
AU2023409104A1
(en)
|
2022-12-21 |
2025-07-31 |
Genzyme Corporation |
Anti‑pd‑1×4‑1bb binding proteins
|
|
TW202440614A
(zh)
|
2022-12-23 |
2024-10-16 |
比利時商艾伯霖克斯公司 |
基於蛋白質的接合載體
|
|
KR20250133750A
(ko)
|
2023-01-09 |
2025-09-08 |
오디세이 테라퓨틱스, 인코포레이티드 |
항-tnfr2 항원-결합 단백질 및 그의 용도
|
|
EP4655323A1
(en)
|
2023-01-27 |
2025-12-03 |
Vrije Universiteit Brussel |
Cd8b-binding polypeptides
|
|
EP4655324A1
(en)
|
2023-01-27 |
2025-12-03 |
Vib Vzw |
Cd163-binding conjugates
|
|
WO2024168279A2
(en)
|
2023-02-10 |
2024-08-15 |
Amunix Pharmaceuticals, Inc. |
Compositions targeting prostate-specific membrane antigen (psma) and methods for making and using the same
|
|
WO2024170756A1
(en)
|
2023-02-17 |
2024-08-22 |
Ablynx N.V. |
Polypeptides binding to the neonatal fc receptor
|
|
WO2024175787A1
(en)
|
2023-02-24 |
2024-08-29 |
Vrije Universiteit Brussel |
Anti-inflammatory pannexin 1 channel inhibitors
|
|
AU2024234615A1
(en)
|
2023-03-14 |
2025-08-21 |
Odyssey Therapeutics, Inc. |
Anti-cd25 antigen-binding proteins and uses thereof
|
|
WO2024194686A2
(en)
|
2023-03-17 |
2024-09-26 |
Oxitope Pharma B.V. |
Anti-phosphocholine antibodies and methods of use thereof
|
|
WO2024194685A2
(en)
|
2023-03-17 |
2024-09-26 |
Oxitope Pharma B.V. |
Anti-phosphocholine antibodies and methods of use thereof
|
|
CN121013863A
(zh)
|
2023-03-31 |
2025-11-25 |
艾菲赛尔治疗株式会社 |
Tnfr2结合多肽及使用方法
|
|
FR3147278A1
(fr)
|
2023-03-31 |
2024-10-04 |
Avacta Life Sciences Limited |
Polypeptides de liaison au tnfr2 et procedes d'utilisation
|
|
WO2024208816A1
(en)
|
2023-04-03 |
2024-10-10 |
Vib Vzw |
Blood-brain barrier crossing antibodies
|
|
WO2024226410A1
(en)
|
2023-04-24 |
2024-10-31 |
Merck Sharp & Dohme Llc |
Trop2 binders and conjugates thereof
|
|
WO2024231447A1
(en)
|
2023-05-08 |
2024-11-14 |
Sanofi |
Glycosylation of immunoglobulin single variable domains
|
|
WO2024231348A1
(en)
|
2023-05-11 |
2024-11-14 |
Vib Vzw |
Slc4a4/nbce1 inhibitors
|
|
AU2024273077A1
(en)
|
2023-05-17 |
2025-11-13 |
Odyssey Therapeutics, Inc. |
Modified single-domain antibodies
|
|
WO2024251783A1
(en)
|
2023-06-05 |
2024-12-12 |
Sanofi |
Predicting thermal stabilities of immunoglobulin single variable domains using machine-learning models
|
|
TW202515916A
(zh)
|
2023-06-22 |
2025-04-16 |
比利時商艾伯霖克斯公司 |
靶向pd-l1的免疫球蛋白單可變結構域
|
|
WO2024261235A1
(en)
|
2023-06-22 |
2024-12-26 |
Ablynx Nv |
Chimeric proteins for modulating cytokine receptor activity
|
|
WO2024261344A1
(en)
|
2023-06-23 |
2024-12-26 |
Vib Vzw |
Novel binders targeting the multi-drug resistant pathogen acinetobacter baumannii
|
|
TW202515917A
(zh)
|
2023-06-29 |
2025-04-16 |
美商奧迪希治療公司 |
抗trailr2抗原結合蛋白及其用途
|
|
AR133188A1
(es)
|
2023-07-05 |
2025-09-03 |
Ablynx Nv |
ANTAGONISTAS DE FcRn MEJORADOS PARA EL TRATAMIENTO DE ENFERMEDADES Y TRASTORNOS RELACIONADOS CON IgG
|
|
US20250051434A1
(en)
|
2023-08-11 |
2025-02-13 |
Merck Sharp & Dohme Llc |
Monovalent interleukin 12 (il-12) heterodimeric fc proteins
|
|
TW202525845A
(zh)
|
2023-08-23 |
2025-07-01 |
法商賽諾菲公司 |
基於ｃｔｌａ—４之溶體降解劑及其用途
|
|
WO2025051767A1
(en)
|
2023-09-04 |
2025-03-13 |
Sanofi |
Polypeptides for use in the treatment of glypican-3-expressing tumours
|
|
TW202532432A
(zh)
|
2023-09-22 |
2025-08-16 |
比利時商艾伯霖克斯公司 |
二及多價白蛋白結合劑
|
|
WO2025080751A2
(en)
|
2023-10-13 |
2025-04-17 |
Odyssey Therapeutics, Inc. |
Anti-cdh17 antigen-binding proteins and uses thereof
|
|
US20250154262A1
(en)
|
2023-10-25 |
2025-05-15 |
Ablynx N.V. |
Fc DOMAIN VARIANTS WITH ENHANCED Fc RECEPTOR BINDING
|
|
WO2025093683A1
(en)
|
2023-11-03 |
2025-05-08 |
Neuvasq Biotechnologies Sa |
Wnt7 signaling agonists
|
|
WO2025099632A1
(en)
|
2023-11-08 |
2025-05-15 |
Sanofi |
Cd25 based lysosomal degrader and uses thereof
|
|
WO2025109176A1
(en)
|
2023-11-22 |
2025-05-30 |
Exevir Bio Bv |
Optimized sarbecovirus spike s2 subunit binders and compositions comprising the same
|
|
WO2025114555A1
(en)
|
2023-11-30 |
2025-06-05 |
Oncospear Aps |
Anti-cd163 antibodies with improved adcc capabilities
|
|
US20250296991A1
(en)
|
2023-12-01 |
2025-09-25 |
Ablynx N.V. |
Precision activated polypeptides
|
|
WO2025125577A1
(en)
|
2023-12-14 |
2025-06-19 |
Vib Vzw |
Antibodies against influenza b virus
|
|
WO2025133166A1
(en)
|
2023-12-22 |
2025-06-26 |
Ablynx Nv |
Protein-based carriers for site-specific amine conjugation
|
|
WO2025133252A1
(en)
|
2023-12-22 |
2025-06-26 |
Ablynx Nv |
Immunoglobulin single variable domains targeting ceacam5
|
|
WO2025133253A2
(en)
|
2023-12-22 |
2025-06-26 |
Ablynx Nv |
Protein-based conjugation carriers for intranuclear delivery
|
|
WO2025154058A1
(en)
|
2024-01-21 |
2025-07-24 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Anti-insect hsp70 nanobodies and uses thereof
|
|
WO2025154056A1
(en)
|
2024-01-21 |
2025-07-24 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Anti-insect cda nanobodies and uses thereof
|
|
WO2025174825A2
(en)
|
2024-02-12 |
2025-08-21 |
Aera Therapeutics, Inc. |
Delivery compositions
|
|
WO2025181155A1
(en)
|
2024-02-26 |
2025-09-04 |
Vib Vzw |
Human beta-glucocerebrosidase binders and uses thereof
|
|
GB202403780D0
(en)
|
2024-03-15 |
2024-05-01 |
Avacta Life Sciences Ltd |
Polypeptides and methods for detecting and quantifying small molecules
|
|
WO2025196308A1
(en)
|
2024-03-22 |
2025-09-25 |
Vib Vzw |
Means and methods for displaying fc-containing proteins on cells and selection thereof
|
|
WO2025207946A1
(en)
|
2024-03-28 |
2025-10-02 |
Genzyme Corporation |
Polypeptides binding to a specific epitope of the transferrin receptor 1
|
|
WO2025217240A1
(en)
|
2024-04-10 |
2025-10-16 |
Odyssey Therapeutics, Inc. |
Anti-tnfr2 antigen-binding proteins and uses thereof
|
|
WO2025219231A1
(en)
|
2024-04-15 |
2025-10-23 |
Vib Vzw |
Computer-implemented means and methods for the de novo design of antibodies targeting a specific epitope
|
|
WO2025229159A1
(en)
|
2024-05-01 |
2025-11-06 |
Commit Biologics Aps |
Antibodies and antibody constructs against cd20
|
|
WO2025238157A1
(en)
|
2024-05-15 |
2025-11-20 |
Katholieke Universiteit Leuven |
Multispecific binding agent suitable for use in cancer immune therapy
|
|
WO2025255435A2
(en)
|
2024-06-07 |
2025-12-11 |
Odyssey Therapeutics, Inc. |
Antigen-binding proteins against serum albumin and uses thereof
|
|
WO2025255558A2
(en)
|
2024-06-07 |
2025-12-11 |
Odyssey Therapeutics, Inc. |
Anti-thymic stromal lymphopoietin (tslp) antigen-binding proteins and uses thereof
|
|
WO2025257408A1
(en)
|
2024-06-14 |
2025-12-18 |
Sanofi |
Treatment of solid organ transplant subjects with cd28/ox40 bispecific antibodies
|